1993
DOI: 10.1042/bst021325s
|View full text |Cite
|
Sign up to set email alerts
|

Differences in the potency of ACAT inhibitors in two assay systems

Abstract: Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors have been shown to prevent cholesterol absorption in the intestine [l], cholesterol storage and apo B secretion from the liver [2], and cholesterol accumulation in the aortic artery [3,4]. Compounds have been established as ACAT inhibitors by their ability to inhibit incorporation of labelled fatty acyl CoA into cholesteryl esters i n microsomal preparations. This assay involves an unknown amount of cholesterol and modulators of the enzyme may be present [… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1995
1995
1997
1997

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Second, whether the inhibitor potentiated the suppressive effect of fish-oil feeding on VLDL secretion. YM17E was chosen as it is a potent inhibitor of Acyl-coAcholesterol acyltransferase (ACAT) [9].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Second, whether the inhibitor potentiated the suppressive effect of fish-oil feeding on VLDL secretion. YM17E was chosen as it is a potent inhibitor of Acyl-coAcholesterol acyltransferase (ACAT) [9].…”
mentioning
confidence: 99%
“…Second, whether the inhibitor potentiated the suppressive effect of fish-oil feeding on VLDL secretion. YM17E was chosen as it is a potent inhibitor of Acyl-coAcholesterol acyltransferase (ACAT) [9].Male Wistar rats were fed for two weeks with either a fish-oil [FO] diet or a normal low-fat [LF] diet. The FO diet consisted of 20% (v/w) Maxepa mixed with the LF diet.…”
mentioning
confidence: 99%